) and a reduced form (NADH). NAD + plays crucial roles in cancer metabolism, including in cellular signaling, energy production and redox regulation. However, it remains unclear whether NAD(H) pool size (NAD + and NADH) could be used as biomarker for colon cancer progression. Here, we showed that the NAD(H) pool size and NAD + /NADH ratio both increased during colorectal cancer (CRC) progression due to activation of the NAD + salvage pathway mediated by nicotinamide phosphoribosyltransferase (NAMPT). The NAMPT expression was upregulated in adenoma and adenocarcinoma tissues from CRC patients.
| INTRODUC TI ON
Worldwide, colorectal cancer (CRC) is the third most common cancer diagnosed in men and the second most common in women. It also has the fourth highest cancer mortality rate in men and the third highest in women. 1 The vast majority of CRC cases are linked to environmental causes, such as diet, exercise, weight, food-borne mutagens, specific intestinal commensals and chronic intestinal inflammation. 2 For example, patients with inflammatory bowel disease, such as ulcerative colitis or Crohn's disease, are 5 to 7 times more likely to develop CRC. [3] [4] [5] [6] In addition to cancer cells, tumors are composed of various immune and inflammatory cells, including macrophages, neutrophils and T lymphocytes. These cells can influence cancer cells via the production of cytokines, chemokines, growth factors and reactive oxygen species (ROS). 7 ROS cause DNA damage, resulting in an accumulation of gene mutations, and activate specific signaling pathways that promote tumor development. 8 However, if
ROS levels increase over a certain threshold that is unfavorable for cellular survival, they may induce cytotoxicity and limit cancer progression. 9 Cancer cells should survive under metabolic stress conditions, such as nutrient deprivation, hypoxia and inflammation, which lead to the accumulation of excessive ROS levels during cancer progression. 10 For cancer to progress under such circumstances, cancer cells must acquire adaptive mechanisms for protection against the potential toxic effects induced by elevated ROS levels.
Nicotinamide adenine dinucleotide (NAD) is a critical coenzyme that exists in both oxidized (NAD + ) and reduced (NADH) forms. In mammals, NAD + is biosynthesized via 2 major pathways: the de novo and salvage pathways. 11 The salvage pathway is important for the maintenance of NAD + levels in cancer cells and works via 2 major pathways, one using nicotinamide phosphoribosyltransferase (NAMPT) and the other using nicotinate phosphoribosyltransferase (NAPRT). NAMPT acts as a rate-limiting enzyme in the salvage pathway and works by transferring a phosphoribosyl group to nicotinamide (NAM) to form nicotinamide mononucleotide (NMN). NMN is then converted into NAD + by nicotinamide mononucleotide adenylyltransferase (NMNAT). NAPRT is involved in the synthesis of NAD + from nicotinic acid. 12 NAMPT is upregulated in various cancer types, including prostate, breast, colorectal, gastric and liver cancers, 13 and could be induced in response to stressors such as genotoxic stress and nutrient deprivation. 14 FK866, a specific inhibitor of NAMPT, has been reported to inhibit breast cancer progression in a xenograft model, 15 and colon cancer progression in an inflammation-induced model. 16 Cancer cells are reported to have a high rate of NAD + turnover and a low ratio of cytosolic NAD + /NADH due to their elevated metabolic needs. 12 Therefore, it remains to be resolved whether the NAD + /NADH ratio and the NAD(H) pool size can regulate cancer progression and the underlying mechanism.
Because NADH is autofluorescent, it can be utilized in nondestructive optical imaging techniques without the use of exogenous labeling agents. Indeed, the redox ratio, which is the fluorescence intensity ratio of NADH and FAD (NADH/FAD), is commonly used in optical metabolic imaging methods. Previous studies demonstrated that the redox ratio was increased in human papillomavirustransformed cells and estrogen receptor-positive breast cancer cell lines. 17, 18 Two-photon excitation fluorescence (TPEF) microscopy is well suited for high-resolution, 3-dimensional, non-invasive measurements of deep regions within living tissue. 19, 20 The detection of NADH by TPEF microscopy during CRC progression in a noninvasive manner would be important for developing not only a diagnostic biomarker but also therapeutics targets associated with NAD + pathways.
In the present study, we investigated the correlation between the NAD(H) pool size and CRC progression and evaluated NADH as a potential prognostic marker. The NAD(H) pool size was increased during colon cancer progression by activating the salvage pathway of NAD + synthesis and could protect tumor cells from excessive oxidative stress induced by inflammation. NADH fluorescence intensity, as measured by TPEF microscopy, was consistently elevated in tumor tissues from CRC patients, suggesting that NADH fluorescence intensity could be a biomarker for CRC progression. II, Leica, Wetzlar, Germany).
| MATERIAL S AND ME THODS

| Reactive oxygen species assay
| Statistical analysis
Statistical analyses were performed using a 2-tailed Student's t test.
P < .05 was considered statistically significant. All samples except for animal samples were prepared in triplicate for every experiment.
The data represent at least 3 independent experiments and are presented as the mean ± SD. NADH levels. E, NADH fluorescence was detected in gut epithelial cells and CRC cell lines by two-photon excitation fluorescence (TPEF) microscopy (scale bar, 50 μm). F, mRNA levels of nicotinamide phosphoribosyltransferase (NAMPT), nicotinate phosphoribosyltransferase (NAPRT), NMNAT1, CD38 and PARP were assessed by quantitative RT-PCR analysis. G, Protein levels were measured by western blotting using whole-cell lysates. H, I, Protein levels were analyzed by densitometry using the ImageJ software. The bars represent the mean ± SD (n = 9). *P < .05 by Student's t test larger in the CRC cell lines than in normal gut epithelial cells due to the increase in both the NAD + and NADH levels ( Figure 1A -C). The NAD + /NADH ratio was also higher in the CRC cell lines ( Figure 1D ).
| Study approval
In addition, NADH fluorescence detected using TPEF microscope at a 740-nm wavelength was consistently stronger in the CRC cell lines than in the normal gut epithelial cells, InEpC and CCD-18Co cells ( Figure 1E ). Therefore, CRC cells were found to maintain a large 
| NADH fluorescence reflects the NAD(H) pool size
We next examined whether inhibition of the enzymes NAMPT,
NAPRT and NMNAT1 could decrease NAD + and NADH levels.
Knockdown of NAPRT or NMNAT1 barely reduced the NAD + and NADH levels, whereas knockdown of NAMPT significantly decreased both the NAD + ( Figure 2A ) and NADH ( Figure 2B ) levels, leading to a reduced NAD(H) pool ( Figure 2C ). The NAD + / NADH ratio was also reduced by NAMPT knockdown ( Figure 2D ). for 4 hours ( Figure 2M,N) , suggesting that the NADH fluorescence intensity using TPEF microscopy could be positively correlated with the NADH pool size.
Both NADH and NADPH can be excited at the same wavelength; therefore, we further investigated the influence of NADPH on the fluorescence intensity determined by TPEF microscopy at a 740-nm wavelength. For this purpose, we transfected siRNA specific to glucose-6-phosphate dehydrogenase (G6PD), an enzyme that is critical for NADPH production ( Figure S1E ). G6PD knockdown specifically downregulated NADPH levels ( Figure S1A-D) and did not reduce the fluorescence intensity ( Figure S1E,F) .
The NAD(H) pool size was increased in azoxymethane/dextran sodium sulfate (AOM/DSS)-induced colorectal cancer. A, Experimental scheme used to induce colorectal cancer (CRC) formation in C57BL/6 mice: after an initial injection of 10 mg/kg AOM, 2% DSS was administered via the drinking water, followed by normal drinking water. B, Representative images of excised mouse colon tissues. Mice were killed 2 mo after DSS treatment (n = 5 per time point). C, Tumor tissues were embedded in paraffin and sectioned (5 μm thick). were treated with 800 μmol/L H 2 O 2 or 1 mmol/L NAC for 24 h. Cell death was assessed by trypan blue staining. G, RKO cells were treated with 800 μmol/L H 2 O 2 for 12 h. ROS measurements were performed using carboxy-H 2 DCFDA. The bars represent the mean ± SD (n = 9). *P < 0.05 by Student's t test. a.u., arbitrary unit during CRC progression and that imaging NADH fluorescence using TPEF microscopy could be a robust method for detecting tumor tissue in AOM/DSS mice.
| Increases in the NAS(H) pool by nicotinamide phosphoribosyltransferase protect cancer cells against detrimental oxidative stress
Azoxymethane/dextran sodium sulfate mice have been widely utilized to examine the role of inflammation in colon carcinogenesis and the contribution of inflammation-induced ROS production to CRC progression. 21 Because NAMPT has been reported to increase the antioxidant capacity of tumor cells, 15 we investigated whether the NAD(H) pool increased by NAMPT would regulate the inflammation-induced ROS levels in AOM/DSS mice. The ROS levels were significantly increased in AOM/DSS mice ( Figure 4A ).
Interestingly, the regions of tumor tissues with high levels of NADH exhibited low levels of ROS relative to the surrounding regions with low levels of NADH ( Figure 4A ). To confirm that ROS production was increased by inflammatory cytokines and immune cells in 
| FK866 inhibits colorectal cancer progression in azoxymethane/dextran sodium sulfate mice
To investigate whether NAMPT inhibition could suppress CRC progression in AOM/DSS mice, FK866 was i.p. injected into mice 21 days after DSS treatment ( Figure 5A ). We confirmed that FK866 treatment suppressed AOM/DSS-induced progression of CRC by imaging the large intestine ( Figure 5B ). FK866 treatment did not induce morphological changes in the gut crypt organization ( Figure 5C ), although the tumor surface area was reduced by FK866 ( Figure 5D ).
FK866 treatment decreased NADH fluorescence intensity and significantly increased ROS levels in AOM/DSS mice ( Figure 5E ). These data indicated that FK866 could inhibit CRC progression in AOM/ DSS mice by causing excessive accumulation of ROS.
| The NAD(H) pool increases in human colorectal tumor tissue
As noted above, larger NAD(H) pools were observed in CRC cell lines and AOM/DSS mouse tissues than in normal cell lines and normal gut tissue. Therefore, we examined whether the NAD(H) pool size was also increased in tumor tissues from adenocarcinoma patients (Table   S1 ). Similar to AOM/DSS mice, the NADH fluorescence intensity was significantly stronger in tumor tissue than in non-tumor tissue ( Figures 6A,C and S3A-G) . In contrast, FAD fluorescence intensity was reduced in CRC tissue compared with non-tumor tissue, leading to an increased redox ratio in CRC tissue ( Figure 6B ). Consistent with the NADH fluorescence intensity, NAMPT protein levels were also upregulated in tumor tissues (Figures 6D and S3A-G) . Next, we confirmed that the NAMPT mRNA levels were upregulated in adenoma and adenocarcinoma tissues relative to non-tumor tissues collected from patients ( Figure 6E -G and Table S2 ). Our data indicated that upregulated NAMPT expression could increase the NAD(H) pool size in the tumor tissues of CRC patients. Because NADH is autofluorescent, whereas NAD + is not, we examined whether NADH levels could represent the NAD(H) pool size. We confirmed that NADH levels could be positively correlated with the NAD(H) pool size and NAD(H) levels determined by enzymatic assays were also consistent with the fluorescence intensity determined by TPEF microscopy ( Figures 1, 3 and 6 ). These results support that the fluorescence intensities detected by TPEF microscopy could represent the NAD(H) pool size. Furthermore, because NADPH and NADH are spectrally identical, we investigated the effects of NADPH levels on the fluorescence intensity using a TPEF microscope at a 740-nm wavelength. Fluorescence lifetime imaging could differentiate between NADPH and NADH because the fluorescence lifetime of cellular NADPH could be distinct from that of cellular NADH as a result of the different cofactors bound by the enzymes. 26 However, we measured the total NADH and NADPH levels, including unbound and bound forms. Decreasing the NADPH level through G6PD knockdown did not significantly affect the TPEF imaging results because the NADH levels were approximately 2-fold higher than those of NADPH ( Figure S1 ). In addition, the NADPH level should also sustain cancer cell resistance to detrimental oxidative stress because NADPH is an antioxidant molecule. Thus, imaging
by TPEF microscopy at a 740-nm wavelength could indicate the resistance to therapies that can induce oxidative stress. Furthermore, Wang et al 27 showed the typical glandular structures of normal mouse colon by TPEF endoscopy as well. Therefore, NADH imaging by TPEF endoscopy could be a potential strategy for CRC diagnosis.
Reactive oxygen species can act as anti-tumorigenic agents, depending on the cell and tissue types, the location of ROS produc- 
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